Total Payments
$12,956
2024 Payments
$1,210
Companies
63
Transactions
553
Medicare Patients
7,333
Medicare Billing
$834,707
Payment Breakdown by Category
Food & Beverage$12,495 (96.4%)
Gifts$270.00 (2.1%)
Other$155.00 (1.2%)
Education$36.53 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,495 | 545 | 96.4% |
| Gift | $270.00 | 1 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $155.00 | 2 | 1.2% |
| Education | $36.53 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,556 | 84 | $0 (2024) |
| Lilly USA, LLC | $997.47 | 45 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $933.41 | 35 | $0 (2024) |
| Novo Nordisk Inc | $905.60 | 52 | $0 (2024) |
| Amgen Inc. | $888.02 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $823.88 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $658.88 | 23 | $0 (2023) |
| GlaxoSmithKline, LLC. | $433.63 | 21 | $0 (2023) |
| Esperion Therapeutics, Inc. | $421.77 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $371.59 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,210 | 37 | Xeris Pharmaceuticals, Inc. ($219.59) |
| 2023 | $1,280 | 56 | Bayer Healthcare Pharmaceuticals Inc. ($205.40) |
| 2022 | $1,964 | 80 | Sekisui Diagnostics, LLC ($270.00) |
| 2021 | $1,980 | 83 | SANOFI-AVENTIS U.S. LLC ($317.90) |
| 2020 | $1,314 | 71 | Lilly USA, LLC ($166.25) |
| 2019 | $2,087 | 94 | Amgen Inc. ($309.18) |
| 2018 | $1,224 | 65 | AstraZeneca Pharmaceuticals LP ($227.26) |
| 2017 | $1,899 | 67 | SANOFI-AVENTIS U.S. LLC ($311.52) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 09/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Obesity | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Inflammation | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,508 | 3,327 | $654,450 | $210,629 |
| 2022 | 23 | 1,507 | 2,342 | $355,471 | $150,978 |
| 2021 | 23 | 1,830 | 4,719 | $865,301 | $243,094 |
| 2020 | 50 | 2,488 | 5,359 | $890,810 | $230,006 |
Total Patients
7,333
Total Services
15,747
Medicare Billing
$834,707
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 225 | 1,146 | $286,500 | $60,175 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 431 | $96,975 | $46,968 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 108 | 164 | $53,300 | $26,240 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $39,250 | $23,390 | 59.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 225 | $33,875 | $17,156 | 50.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 119 | 347 | $34,700 | $10,250 | 29.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 19 | 23 | $24,500 | $4,501 | 18.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 19 | 45 | $22,500 | $4,109 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 72 | $7,200 | $3,523 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 194 | 389 | $9,725 | $3,263 | 33.6% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 19 | 19 | $6,650 | $2,744 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,250 | $1,588 | 37.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 23 | 23 | $3,450 | $1,247 | 36.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 90 | $11,250 | $1,189 | 10.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 24 | 24 | $3,600 | $992.88 | 27.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 18 | $3,150 | $869.22 | 27.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 20 | $3,000 | $865.07 | 28.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 21 | 26 | $1,950 | $500.71 | 25.7% |
| 90471 | Administration of vaccine | Office | 2023 | 24 | 27 | $2,025 | $452.28 | 22.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 11 | 11 | $2,200 | $311.10 | 14.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 21 | $1,575 | $275.31 | 17.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 15 | $1,125 | $19.05 | 1.7% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 15 | 17 | $1,700 | $0.40 | 0.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 398 | $89,550 | $44,087 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 174 | 174 | $43,525 | $26,691 | 61.3% |
About Robert Polofsky
Robert Polofsky is a Family Medicine healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902830557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Polofsky has received a total of $12,956 in payments from pharmaceutical and medical device companies, with $1,210 received in 2024. These payments were reported across 553 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($12,495).
As a Medicare-enrolled provider, Polofsky has provided services to 7,333 Medicare beneficiaries, totaling 15,747 services with total Medicare billing of $834,707. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Amityville, NY
- Active Since 07/10/2006
- Last Updated 11/01/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902830557
Products in Payments
- FARXIGA (Drug) $1,370
- Vascepa (Drug) $658.88
- TRULICITY (Drug) $564.35
- ENTRESTO (Drug) $499.80
- Aimovig (Biological) $445.16
- SOLIQUA 100/33 (Biological) $389.08
- NEXLIZET (Drug) $374.01
- LEQVIO (Drug) $324.08
- Kerendia (Drug) $298.67
- XARELTO (Drug) $288.53
- JARDIANCE (Drug) $271.95
- TRELEGY ELLIPTA (Drug) $236.52
- Otezla (Drug) $230.04
- TRINTELLIX (Drug) $206.96
- Saxenda (Drug) $202.44
- TOUJEO (Drug) $188.67
- VOQUEZNA (Drug) $184.22
- SOLIQUA (Drug) $181.68
- Belviq (Drug) $175.10
- TOUJEO (Biological) $170.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Amityville
Ms. Elena Stybel, Do, DO
Family Medicine — Payments: $29,948
Family Medicine $29,948
Dr. Danita Ionescu, Md, MD
Family Medicine — Payments: $12,027
Family Medicine $12,027
Dr. Donato Balsamo, D.o, D.O
Family Medicine — Payments: $3,839
Family Medicine $3,839
Dr. Andrew Hararah, D.o, D.O
Family Medicine — Payments: $3,645
Family Medicine $3,645
Dr. Andrew Serpe, M.d, M.D
Family Medicine — Payments: $79.57
Family Medicine $79.57
Dr. Nigar Rehman, Md, MD
Family Medicine
Family Medicine